Internal treatment using beta emitting implants.

The idea

Beta-emitting implants are sealed sources placed inside or next to a tumour so that ionising radiation damages malignant cells while sparing much healthy tissue. A beta emitter is chosen because beta particles have a short range in tissue, so dose falls steeply with distance; this confines the therapeutic effect to the target volume and limits exposure of organs beyond it. The implant may be a wire, seed or plaque, and it can be temporary or permanent. A concrete example is a phosphorus-32 or yttrium-90 source used in targeted internal radiotherapy, where the short beta range means the surrounding tissue receives a high local dose.

What earns the marks

• Beta particles are moderately penetrating but have a finite range in tissue, so the absorbed dose is concentrated near the implant and falls rapidly with distance.
• The implant is a sealed source, so the radioactive material is contained and does not enter the patient's general circulation.
• Choice of radionuclide depends on half-life, beta energy and the required treatment duration; a suitable half-life allows a useful dose rate without unnecessary long-term irradiation.
• The clinical aim is to deliver a high dose to the tumour while keeping dose to healthy tissue and staff as low as reasonably practicable.
• Dose depends on source activity, distance from the source and exposure time, so implant placement and treatment time are planned carefully.
• Staff and patient safety involve time, distance and shielding, plus monitoring and controlled handling of the source.

Common mistakes and how to put them right

• Treating beta particles as having unlimited range.

  Put it right by stating that beta particles have a finite range in tissue and that dose falls steeply beyond it.

• Confusing beta-emitting implants with external beam radiotherapy.

  Put it right by explaining that the source is placed inside or adjacent to the tumour.

• Assuming the implant irradiates the whole body uniformly.

  Put it right by describing the steep dose gradient around the source and the need to protect healthy tissue.

Exam tips

• Name the emission type and explain how its range in tissue produces a localised dose.
• Link half-life and activity to the practical treatment schedule rather than quoting them in isolation.
• Use the principles of time, distance and shielding when discussing safety for staff and the patient.